【摘要】  药物治疗是减少冠心病介入术后支架内再狭窄、降低远期主要心血管事件的主要手段。中医药干预在冠心病介入围手术期中有着独特的优势，为中西医结合治疗冠心病的发展提供了新契机。【关键词】  冠心病；介入治疗；中医药 【Abstract】  Medicine treatment plays key role in reducing the rate of restenosis and major adverse cardiac events. Chinese traditional medicine has special advantages in patients with coronary heart disease underwent percutaneous coronary intervention and offers new opportunity for the development of integrated traditional Chinese and Western Medicine.【Keywords】  Coronary heart disease; Percutaneous coronary intervention; Chinese traditional medicine

      1977年9月Gruentzig进行了世界上第一例经皮冠状动脉腔内成形术（percutaneous transluminal coronary angioplasty，PTCA），开创了介入心脏病学的新纪元。此后，以PTCA术和冠脉内支架植入术为基础的